Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin 16 pseudogene 1 (KRT16P1) is classified as a type I keratin pseudogene in the human genome[3]. Pseudogenes are non-functional genomic segments related to genes that typically do not produce functional proteins and play no established role in cellular biology or disease. Unlike protein-coding keratin genes, which support epithelial structure and integrity, KRT16P1 does not participate in cellular or tissue architecture, signaling, or pathogenesis. It does not encode a therapeutic target and has no direct role in pharmacology or disease[3][4]. If you need information on keratin 16 (KRT16), which is a protein-coding gene involved in epidermal integrity and several skin diseases, refer to "Keratin 16 (KRT16)", not the pseudogene KRT16P1[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin 16 pseudogene 1 (KRT16P1).